HomeOrganizations › FLORIDA SOCIETY OF CLINICAL ONCOLOGY INC

FLORIDA SOCIETY OF CLINICAL ONCOLOGY INC

FL · Disease Research · EIN 592305471

2
Executives Disclosed
$3.8M
Annual Revenue
$5.9M
Total Assets
1.5:1
Internal Pay Ratio

FLORIDA SOCIETY OF CLINICAL ONCOLOGY INC has 2 executives with disclosed compensation. The highest-paid executive, Julie Newberry (EXECUTIVE DIRECTOR), received peak total compensation of $206,792. The sector average for Disease Research executives is $215K.


Top Executive Compensation Over Time


Executive Compensation

Name Title Peak Comp. Latest Comp. Years vs. Household
Julie Newberry EXECUTIVE DIRECTOR $207K $207K 2019–2024 2.8x
Dorothy Green Phillips EXECUTIVE DI $146K $137K 2016–2019 1.9x

Annual Summary

Year Executives Avg. Comp. Highest Comp. Total Payroll
2016 1 $0 $0 $0
2017 1 $0 $0 $0
2018 1 $0 $0 $0
2019 2 $137K $137K $137K
2020 1 $0 $0 $0
2021 1 $0 $0 $0
2022 1 $0 $0 $0
2023 1 $174K $174K $174K
2024 1 $207K $207K $207K
Email Alerts

Get notified about FLORIDA SOCIETY OF CLINICAL ONCOLOGY INC

Get an email when a new IRS Form 990 filing is posted that includes this organization. We send a confirmation link first - we don't add you to any other list.